| Dec, 30 | Roche support for victims of the tsunami disaster in Asia more.. |
| Dec, 22 | Roche AIDS Walk: employees´ initiative helps children affected by HIV/AIDS more.. |
| Dec, 22 | Pegasys approved for chronic hepatitis B in Switzerland more.. |
| Dec, 20 | Roche´s new Invirase 500 mg receives approval in US after priority review by FDA more.. |
| Dec, 20 | Breakthrough cancer treatment Avastin approved in Switzerland more.. |
| Dec, 15 | New structure of the Roche Corporate Executive Committee more.. |
| Dec, 9 | Roche submits Boniva, the 1st injectable bisphosphonate for osteoporosis, to FDA more.. |
| Dec, 7 | Breakthrough MabThera data now shows patients with indolent Non-Hodgkin´s Lymphoma can live longer more.. |
| Nov, 30 | Roche employees at almost 60 sites worldwide participate in the Roche AIDS Walk to support children orphaned by HIV/AIDS more.. |
| Nov, 30 | Unique cancer drug Avastin now shown to improve survival across different metastatic colorectal cancer regimens more.. |
| Nov, 23 | Roche and deCODE announce collaboration to co-develop PDE4 inhibitors for vascular diseases more.. |
| Nov, 22 | Sale of Roche´s consumer health business to Bayer approved by the European antitrust authorities more.. |
| Nov, 19 | US approval for breakthrough lung cancer medicine Tarceva more.. |
| Nov, 15 | Opening of new HIV Centre in Cambodia signifies further progress in efforts to tackle HIV/AIDS more.. |
| Nov, 11 | Pegasys receives new indication in Europe allowing hepatitis C patients with "normal" liver enzyme levels to be treated more.. |
| Nov, 2 | Positive outcome confirms efficacy of MabThera in moderate-severe rheumatoid arthritis more.. |
| Nov, 2 | New data proves Tamiflu effective against human H5N1 and avian H5N1 influenza virus more.. |
| Nov, 1 | At its 10th anniversary celebrations Roche China opens new R&D center in Shanghai more.. |
| Nov, 1 | Pegasys Outperforms the Current Standard of Care in Chronic Hepatitis B more.. |
| Oct, 27 | Roche and Pharmasset join forces to develop new generation hepatitis C therapies more.. |
| Oct, 22 | New Genomic Method Can Identify Disease-Causing Genes with Unprecedented Precision and Speed more.. |
| Oct, 22 | Avastin receives positive opinion in Europe for the treatment of patients with metastatic colorectal cancer more.. |
| Oct, 20 | Roche and Japan Tobacco enter agreement on a novel approach to treat high lipid levels in the blood more.. |
| Oct, 14 | Nine-month sales show continued double-digit growth significantly above the market average more.. |
| Oct, 8 | International Prix Galien 2004: revolutionary HIV drug Fuzeon receives most prestigious award for innovation in pharmaceutical industry more.. |
| Sep, 20 | Significant Survival Benefit for Breakthrough Drug Tarceva in Advanced Pancreatic Cancer more.. |
| Sep, 20 | Bonviva: First once-a-month tablet regimen for the treatment of osteoporosis submitted in Europe more.. |
| Sep, 16 | Roche and Protein Design Labs to jointly develop Zenapax for Asthma more.. |
| Sep, 14 | Roche joins Dow Jones Sustainability Indexes more.. |
| Sep, 1 | First chip-based test for broad diagnostic use in European Union has CE mark more.. |
| Aug, 26 | New hope in fight against advanced lung cancer more.. |
| Aug, 24 | Xeloda improves therapy of patients with early colon cancer more.. |
| Aug, 23 | New perspectives in the fight against autoimmunity more.. |
| Aug, 21 | Composer Chen Yi receives second Roche Commission more.. |
| Aug, 10 | Roche gets European approval for MabThera in first line treatment of indolent non-Hodgkin´s lymphoma more.. |
| Jul, 27 | New cancer and diabetes services inaugurated on Phelophepa Healthcare Train in rural South Africa more.. |
| Jul, 21 | Half-Year Media Conference more.. |
| Jul, 21 | First half of 2004: Roche posts market share gains on double-digit sales growth; earnings performance improves significantly more.. |
| Jul, 19 | Roche to sell its consumer health business - clear focus on pharmaceuticals and diagnostics more.. |
| Jul, 8 | New phase III study successfully shows that the benefit of Bonviva/Boniva given by injection once every 2 or 3 months is equivalent to daily oral administration more.. |
| Jun, 23 | Roche to strengthen global leadership in biotechnology manufacturing more.. |
| Jun, 22 | European Commission approves Herceptin plus Taxotere as first-line therapy in HER2-positive metastatic breast cancer more.. |
| Jun, 8 | Roche further reduces prices of HIV protease inhibitor medicines for low and lower middle income countries more.. |
| Jun, 7 | Roche at ASCO: Important data underscore Roche´s leading position in oncology more.. |
| May, 26 | Supplemental new drug application for once-monthly Boniva in osteoporosis submitted to FDA more.. |
| May, 25 | Roche will not exercise its opt-in right for Basilea´s novel antibiotic more.. |
| May, 17 | Roche funds a new international foundation for anemia research more.. |
| May, 11 | Phase III Xeloda colon cancer study (X-Act) meets primary endpoint more.. |
| May, 10 | New 10 year agreement between Roche and Hitachi to become market leader in multibillion dollar immunochemistry sector more.. |
| May, 5 | Roche R&D Day 2004 highlights company´s focus on clinically differentiated medicines more.. |
| Apr, 26 | New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer more.. |
| Apr, 26 | R1549 does not meet primary endpoint in phase III study in ovarian cancer more.. |
| Apr, 22 | CellCept´s cardioprotective profile reinforced more.. |
| Apr, 21 | First quarter exceeds expectations: 15% rise in sales results in further market share gains; Avastin successfully launched in United States more.. |
| Apr, 19 | Amplicor HPV, new diagnostic test to detect cancer causing viruses, launched in Europe more.. |
| Apr, 13 | MabThera: Primary endpoints of phase III trial met two years early due to superior efficacy benefits in relapsed indolent non-Hodgkin´s lymphoma more.. |
| Apr, 6 | Roche´s Annual General Meeting 2004 more.. |
| Apr, 2 | Roche and ArQule form strategic alliance in oncology more.. |
| Mar, 31 | Roche expands reporting on sustainability more.. |
| Mar, 24 | Xenical: European Commission approves label extension more.. |
| Feb, 27 | Breakthrough cancer treatment Avastin receives first approval in the US more.. |
| Feb, 16 | Roche completes acquisition of Igen more.. |
| Feb, 12 | Pegasys and Copegus achieve highest sustained virological response ever achieved in HIV-HCV co-infected patients more.. |
| Feb, 4 | Roche in 2003: growth significantly outpaces global market - strong operating performance - net income of 3.1 billion Swiss francs more.. |
| Feb, 4 | Annual Media Conference more.. |
| Feb, 2 | Roche´s Corporate Sustainability website launched more.. |
| Feb, 2 | Roche scientists identify small molecules that activate a key tumour suppressor pathway more.. |
| Jan, 29 | Roche´s oral flu drug Tamiflu could be effective in treating avian influenza more.. |
| Jan, 19 | Roche files MabThera Marketing Application in Europe for use in first line indolent Non-Hodgkin´s Lymphoma (NHL) more.. |
| Jan, 16 | New R&D centre in China more.. |
| Jan, 15 | Roche chosen by William J. Clinton Presidential Foundation to support HIV/AIDS initiative more.. |
| Jan, 13 | New phase III study successfully shows benefit of oral monthly Bonviva/Boniva in management of osteoporosis more.. |
| Jan, 6 | Following the successful development of Fuzeon Roche and Trimeris sign new research agreement to develop next generation HIV fusion inhibitors more.. |
print this page